| Ytd | -7.18% | |
| 1y | -0.79% |
| Open | 1.81 | Prev Close | 1.81 | Low | 1.79 | High | 1.89 | Mkt Cap | 197.45M |
| Vol | 323.00K | Avg Vol | 1.00M | EPS | -0.50 | P/E | -3.75 | Forward P/E | -5.68 |
| Beta | 0.07 | Short Ratio | 0.31 | Inst. Own | 24.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.69 | 200-d Avg | 1.82 | 1yr Est | 8.00 |
PRQR News
ProQR Therapeutics (NASDAQ: PRQR - Get Free Report) and Artiva Biotherapeutics (NASDAQ: ARTV - Get F
ProQR Therapeutics N.V. (NASDAQ: PRQR - Get Free Report) has received an average rating of "Moderate
ProQR Therapeutics (PRQR) has transitioned its RNA editing platform from preclinical promise to demo
Top analysts change outlook on top names: BMO, Chardan, Rosenblatt, Susquehanna, Evercore, Deutsche
LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target
AX-0810 target engagement data in healthy volunteers on track for Q2 2026; biliary atresia selected
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
ProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (
ProQR Therapeutics (NASDAQ: PRQR) outlined multiple pipeline updates and development priorities duri
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (
ProQR and Ginkgo Bioworks to collaborate on autonomous lab high throughput data generation to suppor
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript
ProQR (PRQR) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate o
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced a
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is estimated to report quarterly ear
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Wednesday, 160 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
On Friday, 313 companies hit new 52-week lows.
On Wednesday, 115 companies reached new 52-week lows.
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid
Stocks That Hit 52-Week Lows On Monday
26 Stocks Moving in Wednesday's Pre-Market Session
Stocks Which Set New 52-Week High Yesterday, September 11th
Stocks Which Set New 52-Week High Yesterday, September 5th